First and foremost, a large thank you to NetGalley, David Khara, and Le French Book for providing me with a copy of this book, which allows me to provide you with this review.
Khara returns with the third instalment if the Consortium Thrillers series, turning things around and placing the focus on one of the main characters. As series readers will know well, Eytan Morgenstern has a complex backstory that has remained the central focus to date. Working alongside Jeremy and Jackie Corbin, remembered from the opening novel in the series, Morgenstern seeks to bring the Consortium down once and for all. After the US Government puts a bounty on their heads, Morgenstern and the Corbins must remain active, alongside two other associates who hold great importance to Morgenstern. The Consortium have begun working with the US army to create a new league of soldiers, based on the concept of transhumanism, the creation of a human whose prosthetic limbs hold super strength. Could the Consortium be helping create this ultimate army as a prototype before moving on to look at the larger population, pitting countries against one another? As Morgenstern realises that he is being hunted by the Consortium to resume medical testing, he vows to bring them down before any further damage can be done. With key flashbacks to the creation of Morgenstern as a killer, post-Nazi medical patient, Khara offers an enriching view of this most complex character within the entire series and turns the medical advancements to the present day, exemplifying the horrors that modern-technology could reap on an unsuspecting populace. A great addition to the Consortium Thriller series that may leave readers satisfied or screaming for more.
Having read all three Consortium Thrills consecutively, I have a better idea of what is going on and the flow Khara places within the series. While not his best work, Khara does instil the same horror in the reader as they see the development of what is to come in the world of biological warfare and nanotechnology. The characters are decently presented, though it is only Eytan Morgenstern who receives much backstory. I also felt the constant flitting from present to Morgenstern’s past somewhat distracting, though I can see why Khara presented things in this manner. The plot and premise of the novel are sound, but are not stelar by any stretch. I felt the dialogue and some of the narrative seems a little hokey, which has been an issue throughout the series. That could be from the translation or simply that the book has some inherent stretches to the imagination. Whether this was the last of the Consortium novels or not remains to be seen, though Khara does offer some degree of finality within the story, but as readers of thrillers know well, the Phoenix can always rise from the ashes.
Kudos, M. Khara for this decent addition to the series. I am still using your opening novel as a yardstick, which was highly enticing and cannot help but measure the others against it.